ClinConnect ClinConnect Logo
Search / Trial NCT06251037

"Youth Aware of Mental Health" in Galicia

Launched by FUNDACIN BIOMEDICA GALICIA SUR · Feb 1, 2024

Trial Information

Current as of November 14, 2025

Enrolling by invitation

Keywords

Suicide Awareness Adolescent Behavior Suicide Prevention Intervention Mental Health Literacy

ClinConnect Summary

This study in Galicia, Spain tests whether a school-based program called Youth Aware of Mental Health (YAM) can help prevent serious suicidal thoughts and suicide attempts among teenagers. It is a large, randomized trial in many secondary schools, where each school is assigned to either receive the YAM program or to continue with usual teaching (no extra program) during the study. The intervention group will take part in five one-hour, interactive sessions led by trained instructors; the control group will not receive YAM during the study but will be offered it after the study ends.

Eligible participants are 13 to 16-year-old students in 3rd-year secondary education at participating centers. Parents must give permission, and students aged 12 or older give assent. All students will complete surveys at the start and 12 months later to measure suicidal thoughts and behaviors, mood/depression, willingness to seek help, bullying, and related factors. The main goals are to see if YAM reduces severe suicidal ideation and prevents new suicide attempts compared with schools not receiving the program. Results are not yet available, as the trial is ongoing.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Being a 3rd-year secondary education student at one of the participating school centers
  • To be between 13 and 16 years old
  • Exclusion Criteria:
  • Not meeting the inclusion criteria
  • Note: The YAM is a universal prevention program, therefore, there are no exclusion criteria. Cases with a history of previous suicide attempts (evaluated by the Paykel Scale) in the initial survey will be excluded from the analysis. However, these students will receive the same intervention as the rest of the students. The YAM is not a treatment program and does not aim to demonstrate its efficacy in cases already diagnosed with mental disorders, but it does not exclude individuals with these problems from any potential benefits that participation in the program may have.

About Fundacin Biomedica Galicia Sur

Fundación Biomédica Galicia Sur is a leading clinical research organization dedicated to advancing medical science through innovative research and development. Based in Galicia, Spain, the foundation collaborates with healthcare institutions, academic researchers, and industry partners to facilitate high-quality clinical trials that focus on a range of therapeutic areas. With a commitment to ethical standards and patient-centric approaches, Fundación Biomédica Galicia Sur aims to translate scientific discoveries into effective treatments, ultimately enhancing healthcare outcomes and contributing to the global medical community.

Locations

Ferrol, A Coruñaa, Spain

Ares, A Coruña, Spain

Betanzos, A Coruña, Spain

Betanzos, A Coruña, Spain

Cambre, A Coruña, Spain

Carballo, A Coruña, Spain

Carballo, A Coruña, Spain

Culleredo, A Coruña, Spain

Ferrol, A Coruña, Spain

Ferrol, A Coruña, Spain

Ferrol, A Coruña, Spain

Noia, A Coruña, Spain

Ordes, A Coruña, Spain

Ordes, A Coruña, Spain

Padrón, A Coruña, Spain

Pontedeume, A Coruña, Spain

Sada, A Coruña, Spain

Santiago De Compostela, A Coruña, Spain

Santiago, A Coruña, Spain

Santiago, A Coruña, Spain

Vedra, A Coruña, Spain

Coristanco, Coruña, Spain

Ferrol, Coruña, Spain

Santiago De Compostela, Coruña, Spain

Burela De Cabo, Lugo, Spain

Monterroso, Lugo, Spain

Sarria, Lugo, Spain

Sarria, Lugo, Spain

Sarria, Lugo, Spain

Allariz, Ourense, Spain

Maceda, Ourense, Spain

O Carballiño, Ourense, Spain

O Carballiño, Ourense, Spain

Xinzo De Limia, Ourense, Spain

A Guarda, Pontevedra, Spain

Baiona, Pontevedra, Spain

Cangas, Pontevedra, Spain

Gondomar, Pontevedra, Spain

Marín, Pontevedra, Spain

Marín, Pontevedra, Spain

Moaña, Pontevedra, Spain

Mondariz, Pontevedra, Spain

Poio, Pontevedra, Spain

Redondela, Pontevedra, Spain

Salceda De Caselas, Pontevedra, Spain

Salvatierra De Miño, Pontevedra, Spain

Sanxenxo, Pontevedra, Spain

Soutomaior, Pontevedra, Spain

Tomiño, Pontevedra, Spain

Vigo, Pontevedra, Spain

Vigo, Pontevedra, Spain

Vigo, Pontevedra, Spain

Vigo, Pontevedra, Spain

Vigo, Pontevedra, Spain

Vigo, Pontevedra, Spain

A Coruña, Spain

A Coruña, Spain

Coruña, Spain

Lugo, Spain

Lugo, Spain

Lugo, Spain

Lugo, Spain

Ourense, Spain

Ourense, Spain

Ourense, Spain

Ourense, Spain

Pontevedra, Spain

Santiago De Compostela, Spain

Vigo, Pontevedra, Spain

Ferrol, Spain

Ares, Spain

Betanzos, Spain

Betanzos, Spain

Cambre, Spain

Carballo, Spain

Carballo, Spain

Culleredo, Spain

Ferrol, Spain

Ferrol, Spain

Ferrol, Spain

Noia, Spain

Ordes, Spain

Ordes, Spain

Padrón, Spain

Pontedeume, Spain

Sada, Spain

Santiago De Compostela, Spain

Santiago, Spain

Santiago, Spain

Vedra, Spain

Coristanco, Spain

Ferrol, Spain

Santiago De Compostela, Spain

Patients applied

0 patients applied

Trial Officials

Alejandro García Caballero

Principal Investigator

Servizo Galego de Saude

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported